U.S. Bioscience regulatory update

U.S. Bioscience Inc. (UBS) UBS (West Conshohocken, Penn.) received a notice of compliance to market NeuTrexin (trimetrexate glucuronate for injection) in Canada for treatment of moderate-to-severe Pn...